Infectious Diseases

Host: Linda Bernstein, Pharm.D.

To prevent the flu from spreading concurrently with COVID-19, The U.S. Food and Drug Administration has expanded the approved indication for baloxavir marboxil to include post-exposure prevention of influenza. On this episode of The Drug Report, Dr. Linda Bernstein dives into this oral anti-influenza drug.

Published December 2, 2020

Host: Linda Bernstein, Pharm.D.

With the spread of the COVID-19 pandemic, fewer children have received a measles vaccination, and progress towards eliminating this disease has halted. How can pharmacists encourage more pediatric measles vaccinations? In this episode of The Drug Report, Dr. Linda Bernstein takes a look at the vast number of children globally who’ve yet to receive this vaccine.

Published November 30, 2020

Host: Linda Bernstein, Pharm.D.

Pfizer and BioNTech recently announced that their mRNA vaccine for the COVID-19 virus was 90 percent effective, and the companies plan to apply for Emergency Use Authorization. This episode of The Drug Report dives into this vaccine’s Phase 3 clinical trial and explores developments made by other companies in the search for a COVID-19 vaccine.

Published November 30, 2020

Host: Linda Bernstein, Pharm.D.

This episode of The Drug Report takes a look at a COVID-19 cocktail comprised of the coadministration of casirivimab and imdevimab, which has proven to decrease hospitalization and emergency room visits.

Published November 30, 2020

Host: Linda Bernstein, Pharm.D.

The U.S. Food and Drug Administration has granted Eli Lilly and Company’s trial vaccine for COVID-19 an Emergency Use Authorization, or EUA. On this episode of The Drug Report, learn more about this monoclonal antibody and how the company plans on distributing it.

Published November 30, 2020

Host: Linda Bernstein, Pharm.D.

In light of the COVID-19 pandemic, the Centers for Disease Control and Prevention, or the CDC, plans to use pharmacies to increase access to the COVID-19 vaccine when it is ready for distribution. In this episode of The Drug Report, Linda Bernstein will explain the CDC’s recently-developed Vaccination Program Interim Playbook.

Published November 17, 2020

Host: Matt Birnholz, MD

Guest: Susan R. Bailey, MD

The COVID-19 pandemic has impacted the healthcare field through reductions in patient volume and higher practice costs. How will these economic challenges change health policy and alter the future of healthcare? President of the American Medical Association Dr. Susan R. Bailey joins Dr. Matt Birnholz to discuss their recent survey.

Host: Jennifer Caudle, DO

Guest: Carol Vargo, MHS

Physicians across the country have been working hard to keep their practices operational and their patients, as well as themselves, safe amid the COVID-19 pandemic. Carol Vargo returns to share some tips and resources to help keep healthcare practices open with Dr. Jennifer Caudle.

Host: John E. Anderson, MD

Host: John Buse, MD, PhD

Host: Carol Wysham

The outbreak of the COVID-19 pandemic has pushed healthcare professionals to adjust the way they treat patients with chronic conditions like diabetes. Tune in to hear Drs. John Anderson, John Buse, Carol Wysham share their experience caring for patients with diabetes amid the pandemic.

Host: Linda Bernstein, Pharm.D.

The Food and Drug Administration announced that Remdesivir is the first treatment for COVID-19 to receive their approval. To help us better understand this antiviral agent, Dr. Linda Bernstein discusses emerging studies uncovering the benefits and limitations of Remdesivir.

Published November 6, 2020